ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takamori, S.
Right arrow Articles by Shirouzu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takamori, S.
Right arrow Articles by Shirouzu, K.

Ann Thorac Surg 1996;62:844-847
© 1996 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Expandable Metallic Stents for Tracheobronchial Stenoses in Esophageal Cancer

Shinzo Takamori, MD, Hiromasa Fujita, MD, Akihiro Hayashi, MD, Kohsuke Tayama, MD, Masahiro Mitsuoka, MD, Shoji Ohtsuka, MD, Kazuo Shirouzu, MD

First Department of Surgery, Kurume University School of Medicine, Kurume, Japan

Accepted for publication April 24, 1996.

Background. Tracheobronchial stenosis in patients with esophageal cancer can be life threatening. Few reports have discussed use of expandable metallic stents for central airway stenoses in patients with esophageal cancer.

Methods. Twelve patients with esophageal cancer underwent placement of expandable metallic stents for respiratory distress caused by tracheobronchial stricture. Single or double metallic stents were placed in the stenotic airways under fluoroscopic guidance. Improvement in respiratory symptoms and clinical outcome were assessed.

Results. Most stenoses were located in the trachea or the left main bronchus. From one to four expandable metallic stents were placed in each stricture site, with immediate relief of respiratory symptoms in 8 patients. One patient with tracheomalacia in alive 3 years after stent placement and another is alive 6 months after stent insertion. The other 10 patients lived from 10 to 70 days (mean; survival, 35 days) after stent placement. Death was due to progression of disease.

Conclusions. Although metallic stents are useful for relieving respiratory distress in patients with advanced esophageal cancer, additional therapies should be considered.




This article has been cited by other articles:


Home page
 ChestHome page
K. P. W. Chan, P. Eng, A. A.L. Hsu, G. M. Huat, and M. Chow
Rigid Bronchoscopy and Stenting for Esophageal Cancer Causing Airway Obstruction*
Chest, September 1, 2002; 122(3): 1069 - 1072.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
H.-Y. Song, T. S. Shim, S.-G. Kang, G.-S. Jung, D. Y. Lee, T.-H. Kim, S. Park, Y. M. Ahn, and W. S. Kim
Tracheobronchial Strictures: Treatment with a Polyurethane-covered Retrievable Expandable Nitinol Stent-Initial Experience
Radiology, December 1, 1999; 213(3): 905 - 912.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
A. P. C. Yim, V. J. Abdullah, M. B. Izzat, and S. Takamori
Which Stent to Use for Tracheobronchial Stenoses: Metallic or Silicone?
Ann. Thorac. Surg., May 1, 1997; 63(5): 1512 - 1513.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
F. Venuta, T. De Giacomo, E. A. Rendina, P. Trentino, G. D. Rocca, C. Ricci, and S. Takamori
Double Stents for Carcinoma of the Esophagus Invading the Airway
Ann. Thorac. Surg., May 1, 1997; 63(5): 1515 - 1516.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.